US Patent Issued to Bioverativ USA on Aug. 19 for "Anti-C1S antibodies and methods of use thereof" (California Inventors)

ALEXANDRIA, Va., Aug. 20 -- United States Patent no. 12,391,750, issued on Aug. 19, was assigned to Bioverativ USA Inc. (Waltham, Mass.).

"Anti-C1S antibodies and methods of use thereof" was invented by Sandip Panicker (South San Francisco, Calif.), Graham Parry (South San Francisco, Calif.) and Nancy E. Stagliano (South San Francisco, Calif.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure provides antibodies that specifically bind complement pathway component C1s The present disclosure provides nucleic acids comprising nucleotide sequences encoding the anti-C1s antibodies; and host cells comprising the nucleic acids. The present disclosure provides compositions comprising the anti-C1s ...